Back to Search Start Over

A Review on the Some Biological Activities of the Hydantoin Derivatives.

Authors :
Wadghane, Somnath
Bhor, Rohit
Shinde, Ganesh
Kolhe, Mahesh
Pooja, Rathod
Source :
Journal of Drug Delivery & Therapeutics; Jan2023, Vol. 13 Issue 1, p171-178, 8p
Publication Year :
2023

Abstract

Hydantoin derivatives are commonly used anticonvulsants. In general, they are effective for partialonset seizures and tonic-clonic seizures, but not for absence seizures. Phenytoin is the most important drug in this group, and other drugs, ethotoin, and mephenytoin, are also commonly used to treat epilepsy. Prodrugs such as derivatives have been created. Phenytoin is effective in some cases of trigeminal neuralgia and related neuralgia. Phenytoin is also used to treat arrhythmias. Hydantoins or glycolylureas are heterocyclic organic compounds with the formula CH2C(O)NHC(O)NH. It is a colorless solid formed by the reaction of glycolic acid and urea. It is an oxidized derivative of imidazolidine. In a more general sense, hydantoins can refer to groups and classes of compounds that share the same ring structure as their parent. For example, phenytoin (see below) has two phenyl groups substituted at the 5th carbon of the hydantoin molecule. Actual chemotherapy for epilepsy dates back to the 1850s when "inorganic bromides" were introduced. However, it is worth noting that around the 1920s, the therapeutic and beneficial use of 'phenobarbital' usheredin an era of meaningful treatment of epilepsy. Hydantoin ring chemistry is the synthesis of rings by various methods and their applications in the medical field. Previous descriptions of hydantoin-containing compounds have broad pharmacological and biological activities, including anticancer, anti-inflammatory, anti-immune, antimetabolite, antioxidant, antibacterial, CNS-related, anticonvulsant, antitussive, and cytoprotective activities. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
22501177
Volume :
13
Issue :
1
Database :
Complementary Index
Journal :
Journal of Drug Delivery & Therapeutics
Publication Type :
Academic Journal
Accession number :
161540636
Full Text :
https://doi.org/10.22270/jddt.v13i1.5904